Lung cancer not on many women's radar, survey finds

May 13, 2014 by Amy Norton, Healthday Reporter
Lung cancer not on many women's radar: survey
Although lung cancer is biggest cancer killer, women believe breast cancer is a bigger concern.

(HealthDay)—U.S. women still see breast cancer as a bigger killer than lung cancer, despite the fact that lung cancer kills more Americans each year—women and men—than any other cancer.

That's one of the findings from a new American Lung Association (ALA) survey of over 1,000 adult U.S. .

The poll also found that many women may not appreciate the risk to nonsmokers. And few were aware of just how deadly lung cancer remains, in a time of major progress against some other cancers.

According to Alana Burns, vice president of the ALA's Signature Cause Campaign, the poor survival rate may be one reason that lung cancer is not on women's radar.

"With , there are so many survivors out there telling their stories and advocating," Burns said. "But more than half of women diagnosed with lung cancer are gone within a year. There is no legion of survivors talking about their experiences."

In the United States, breast cancer is the most common cancer among women, followed by lung cancer. But lung cancer is the top killer. According to the U.S. Centers for Disease Control and Prevention, lung cancer kills about 38 out of every 100,000 U.S. women each year. The death rate from breast cancer is 22 per 100,000.

But when the ALA survey respondents were given a list of cancers and asked to pick the top killer of women, 51 percent chose breast cancer. Only 22 percent chose lung cancer.

"It's pretty clear that breast cancer gets more press," said Dr. Subhakar Mutyala, associate director of the Scott & White Cancer Institute in Temple, Texas.

Plus, he said, since there's routine screening for breast cancer, women and their doctors are talking about the disease.

But unless you're a smoker, your doctor is probably not going to bring up lung cancer, noted Mutyala, who reviewed the survey findings. And while it is possible to screen for lung cancer, he added, that's limited to certain high-risk groups.

Right now, the U.S. Preventive Services Task Force recommends annual CT scans for adults aged 55 to 80 who currently smoke or who quit within the past 15 years—and smoked for at least 30 "pack-years." That means one pack per day for 30 years, or two packs a day for 15 years, for example.

Smokers are not, however, the only people who get lung cancer. About 10 percent of people diagnosed with the disease never smoked, the ALA states.

But half of the women in the new survey said they were "not concerned" about lung cancer because they'd never smoked. That included 68 percent of lifelong nonsmokers.

"Many people think of lung cancer as solely a smoker's disease," Burns said.

Yet, she added, if lung cancer in nonsmokers were considered its own disease, it would rank among the top-10 cancer killers in the United States.

Burns and Mutyala said people should be aware of the risk factors for lung cancer in nonsmokers.

The top cause is exposure to radon gas, which can become concentrated in homes that are built on soil with natural uranium deposits. Other risk factors include chronic exposure to secondhand smoke or air pollution, and on-the-job exposure to pollutants such as diesel exhaust and asbestos. Researchers have also found gene mutations that play a role in some lung cancers.
The prognosis for people with lung cancer remains grim, according to the lung association. Less than half of women with the disease are still alive one year after they're diagnosed—a statistic few women in the survey said they'd heard before.

Unfortunately, the cancer is usually diagnosed at a late stage. "Only about 20 percent of lung cancers are operable when people are diagnosed," Mutyala said.

To help improve that outlook, the ALA wants the U.S. National Institutes of Health to boost its funding for lung cancer research—from the current level of $213 million per year, to $400 million by 2025. By comparison, current funding for breast cancer research tops $650 million a year, according to estimates from the U.S. National Institutes of Health.

"That's despite the fact that lung cancer kills more people than breast, prostate and colon cancers combined," Mutyala said.

Burns said women can help by getting involved in efforts to raise awareness and funds. The ALA just launched a new website, dubbed Lung Force (, where people can find information on local charity events, share stories about their experiences with lung cancer, and get information on the disease.

"We want people to learn about the risks," Burns said. "This is something that's relevant to you. You should care."

Explore further: Slight drop in rate of advanced cancers, CDC says

More information: The American Lung Association has facts and figures on lung cancer.

Related Stories

Slight drop in rate of advanced cancers, CDC says

March 27, 2014
(HealthDay)—Rates of invasive cancers in the United States fell slightly from 2009 to 2010, and widespread adoption of colon cancer screening and other measures could push those rates even lower, a federal government study ...

Research insights into lung diseases focus of new centre

April 11, 2014
Coinciding with the launch of a dedicated Lung Health Research Centre, researchers at the University of Melbourne have discovered a new insight into the unexplained link between lung infections, emphysema and lung cancer.

Cancer cases up 11%, breast cancer by a fifth: WHO

December 12, 2013
The number of new cancer cases around the globe jumped by 11 percent in a five-year period, reaching 14.1 million in 2012, with breast cancer increasing by one-fifth, the UN health agency said Thursday.

Increased risk of developing lung cancer after radiotherapy for breast cancer

April 7, 2014
Vienna, Austria: Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount ...

Continued research needed on treatment for women with lung cancer who are never smokers

June 25, 2013
The incidence of lung cancer in women affects an estimated 516,000 women worldwide, of which 100,000 are in the United States and 70,000 in Europe. Until now, lung cancers occurring in women have been treated similarly to ...

Diabetes linked to lung cancer in postmenopausal women

May 30, 2012
(HealthDay) -- Postmenopausal women with diabetes are at a significantly higher risk of developing lung cancer, particularly if they require insulin therapy, according to research published online May 22 in Diabetes Care.

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.